Lymphoma is a type of cancer that starts in the white blood cells (lymphocytes), which are part of the body’s immune system. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. National Cancer Institute statistics estimate that 9,050 people will be diagnosed with Hodgkin lymphoma and 71,850 people will be diagnosed with non-Hodgkin lymphoma in the United States in 2015.
In March 2015, ADC Therapeutics filed an Investigational New Drug application (IND) for HuMax-TAC-ADC for a Phase I trial in patients with relapsed or refractory Hodgkin and non-Hodgkin lymphoma.
Back to top